Sharon A Riddler MD
HIV/AIDS Medicine
Professor, Medicine, University of Pittsburgh School of Medicine
Join to view full profile
3601 5th Ave# PactPittsburgh, PA 15213
Phone+1 412-647-7228
Dr. Riddler is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationFellowship, Infectious Disease, 1991 - 1994
University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 1986 - 1990
Medical College of WisconsinClass of 1986
Certifications & Licensure
PA State Medical License 1991 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification MyUPMC, UPMC, 2012-2017
Clinical Trials
Publications & Presentations
PubMed
- Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.Basma N Dib, Rebecca Zash, Sean Brummel, Modiegi Diseko, Judith Mabuta
AIDS. 2026-10-23 - Female sex is associated with continuous decline in intact HIV-1 proviruses during long-term antiretroviral therapy.Yijia Li, Nadia R Roan, Tom Medvec, Sharon Riddler, Gregory Laird
AIDS. 2026-10-08 - Lenacapavir initiation with concomitant primidone: A case report with therapeutic drug monitoring.Aaron S Devanathan, Thomas Glowa, Emily M Thompson, Amanda J Saylor, Thomas D Nolin
British Journal of Clinical Pharmacology. 2026-10-06
Journal Articles
- Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the MTN-020/ASPIRE Phase III Trial of the Dapivirine Vaginal RingSharon Riddler, MD, Clinical Infectious Diseases
Press Mentions
Urticaria Reported in Trial of Investigational HIV mRNA VaccinesMay 6th, 2025- Minimal Antibody Response in Imbokodo Compels Change of Course for HIV Vaccine ResearchJuly 31st, 2022
- Trial of Three mRNA HIV Vaccines LaunchedMarch 15th, 2022
Grant Support
- Pitt-Ohio State Clinical Trials UnitUNIVERSITY OF PITTSBURGH AT PITTSBURGH2007–2027
- Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional CureUNIVERSITY OF PITTSBURGH AT PITTSBURGH2020–2026
- Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional CureUNIVERSITY OF PITTSBURGH AT PITTSBURGH2017–2025
- Immunotherapy With Autologous Hiv-Loaded Dendritic CellsNational Institute Of Allergy And Infectious Diseases2010–2011
- RAND PHI Eval Immuniz W/Highly Conserved HIV-1 DER PEPT Influ MatrixNational Center For Research Resources2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: